[1]
Labairu-Huerta, L., Padilla-Fernández, B., Arrondo-Arrondo, J.L., Valverde-Martínez, L.S., Martín-Rodríguez, A., Silva-Abuín, J.M., García-Cenador, M.B., Mirón-Canelo, J.A. and Lorenzo-Gómez, M.F. 2015. PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction. Archivio Italiano di Urologia e Andrologia. 87, 3 (Sep. 2015), 204–209. DOI:https://doi.org/10.4081/aiua.2015.3.204.